Bio-Path Holdings Inc. (BPTH) Financial Statements (2025 and earlier)

Company Profile

Business Address 4710 BELLAIRE BOULEVARD
BELLAIRE, TX 77401
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,052,00010,384,00023,774,00013,755,00020,426,0001,004,000
Cash and cash equivalents1,052,00010,384,00023,774,00013,755,00020,426,0001,004,000
Prepaid expense632,0003,587,000523,0001,273,000776,000332,000
Other current assets1,358,0001,644,0001,843,000928,000788,000593,000
Other undisclosed current assets      
Total current assets:3,042,00015,615,00026,140,00015,956,00021,990,0001,929,000
Noncurrent Assets
Operating lease, right-of-use asset102,000198,000203,000288,000367,000
Property, plant and equipment76,000158,000225,000231,000303,000406,000
Total noncurrent assets:178,000356,000428,000519,000670,000406,000
TOTAL ASSETS:3,220,00015,971,00026,568,00016,475,00022,660,0002,335,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,803,0001,576,000876,0001,075,0001,159,0001,117,000
Accounts payable457,000667,000106,000100,000486,000813,000
Accrued liabilities1,346,000909,000770,000975,000673,000304,000
Debt     85,000 
Other undisclosed current liabilities103,000108,00082,00094,000  
Total current liabilities:1,906,0001,684,000958,0001,169,0001,244,0001,117,000
Noncurrent Liabilities
Long-term debt and lease obligation:   153,000236,000330,000 
Liabilities, other than long-term debt 10,000113,000    
Operating lease, liability 10,000113,000153,000236,000330,000
Other undisclosed noncurrent liabilities863,000 (153,000)(236,000)  
Total noncurrent liabilities:873,000113,000153,000236,000330,000 
Total liabilities:2,779,0001,797,0001,111,0001,405,0001,574,0001,117,000
Equity
Equity, attributable to parent441,00014,174,00025,457,00015,070,00021,086,0001,218,000
Common stock1,0008,0007,0005,0004,0001,000
Additional paid in capital108,047,000105,695,000103,111,00082,286,00077,421,00048,957,000
Accumulated deficit(107,607,000)(91,529,000)(77,661,000)(67,221,000)(56,339,000)(47,740,000)
Total equity:441,00014,174,00025,457,00015,070,00021,086,0001,218,000
TOTAL LIABILITIES AND EQUITY:3,220,00015,971,00026,568,00016,475,00022,660,0002,335,000

Income Statement (P&L) (USD)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating expenses(15,843,000)(13,901,000)(10,443,000)(10,908,000)(8,693,000)(8,590,000)
Operating loss:(15,843,000)(13,901,000)(10,443,000)(10,908,000)(8,693,000)(8,590,000)
Nonoperating income (expense)(235,000)33,0003,00026,00094,0007,000
Investment income, nonoperating36,00033,0003,00026,00094,0007,000
Loss from continuing operations before income taxes:(16,078,000)(13,868,000)(10,440,000)(10,882,000)(8,599,000)(8,583,000)
Income tax expense (benefit) (475,000) 77,000(77,000)(2,000)(2,000)
Other undisclosed loss from continuing operations      
Loss from continuing operations:(16,553,000)(13,868,000)(10,363,000)(10,959,000)(8,601,000)(8,585,000)
Loss before gain (loss) on sale of properties:(10,363,000)(10,959,000)(8,601,000)(8,585,000)
Other undisclosed net income (loss)475,000     
Net loss:(16,078,000)(13,868,000)(10,363,000)(10,959,000)(8,601,000)(8,585,000)
Other undisclosed net income (loss) attributable to parent  (77,000)77,0002,0002,000
Net loss available to common stockholders, diluted:(16,078,000)(13,868,000)(10,440,000)(10,882,000)(8,599,000)(8,583,000)

Comprehensive Income (USD)

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(16,078,000)(13,868,000)(10,363,000)(10,959,000)(8,601,000)(8,585,000)
Comprehensive loss, net of tax, attributable to parent:(16,078,000)(13,868,000)(10,363,000)(10,959,000)(8,601,000)(8,585,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: